This website was not designed for Internet Explorer 7.0 or below. Please consider upgrading your browser to one of the following:
Mozilla Firefox | Internet Explorer | Google Chrome | Apple Safari
URI Logo Academic Roadmap® Academic Roadmap Logo
Community College of Rhode Island — Biotechnology

Biopharmaceuticals
Advances in Medicine from Biotechnology

Prior to modern biotechnology, most drugs and medical treatments were limited to what existed already in nature or could be concocted by the local pharmacist. These drugs were often ineffective or had side effects that were worse than the condition itself. Biotechnology’s role in medicine is to develop medicines that are more effective and produce fewer side effects.

Insulin Story

Until the 1980s, diabetic patients were treated with insulin extracted from the pancreas of cows and pigs. Although effective, this proved problematic, as certain patients had allergic reactions to the non-human insulin. The discovery of restriction enzymes in 1970 allowed researchers to remove DNA from one organism and insert it into another. Using this new recombinant DNA technology, we are now able to insert the gene for human insulin into E. coli bacteria and produce it on a large scale. Biotechnology has provided a much more effective way to manufacture this essential drug.

Magic Bullets

Cancer treatment remains one of the greatest challenges to modern medicine. Conventional treatments consist of bombarding the body with chemo-therapeutics that do not discriminate between cancerous cells and healthy cells. The hope is that the treatment destroys the rapidly dividing cancer cells before it damages vital organs. There will be 1.5 million new cases of cancer this year and many of these patients can be helped by advances in biotechnology such as the development of monoclonal antibodies. These antibodies act like the “magic bullets”: they are engineered to look for a specific cell type, so they hunt down and attack only cancer cells. There has been success in the treatment of an aggressive form of breast cancer with Genentech’s monoclonal antibody, Herceptin.

Other Treatments

Other biotechnology products that are in use or in the development pipeline include treatments for Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, psoriasis, and renal disease. Some of these drugs are being researched and produced locally in Rhode Island and Massachusetts.

Links
  • PhRMA – The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.
  • The FDA is the government agency charged with approving new drugs, monitoring drug safety, and regulating drug distribution in the US.
  • MANTA is the largest free source of information on small companies. It offers data on more than 60 million firms worldwide and profiles 54 pharmaceutical companies in Rhode Island.
  • Patent Docs is a blog about biotechnology and pharmaceutical patents. The link provided points to an article about the 25 top biotech drugs.